PARP inhibitor AZD2281 increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma

Passaro C.; Volpe M.; Scamardella E.; Gillespie D.; Libertini S.; Portella G.

首页> 外文期刊>Human gene therapy >PARP inhibitor AZD2281 increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma

【24h】

PARP inhibitor AZD2281 increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma

机译：PARP抑制剂AZD2281在变性间变性甲状腺癌的体内外模型中提高dl922-947的溶瘤活性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Human gene therapy》 |2014年第12期|共1页
作者
Passaro C.; Volpe M.; Scamardella E.; Gillespie D.; Libertini S.; Portella G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. PARP inhibitor AZD2281 increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma [J] . Passaro C., Volpe M., Scamardella E., Human gene therapy . 2014,第12期

机译：PARP抑制剂AZD2281在变性间变性甲状腺癌的体内外模型中提高dl922-947的溶瘤活性
2. Inhibitor of the transcription factor NF-κB, DHMEQ, enhances the effect of paclitaxel on cells of anaplastic thyroid carcinoma in vitro and in vivo [J] . V. V. Pushkarev, D. V. Starenki, V. M. Pushkarev Ukrainian Biochemical Journal . 2015,第3期

机译：转录因子NF-κB抑制剂DHMEQ在体外和体内增强紫杉醇对间变性甲状腺癌细胞的作用
3. Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo. [J] . Catalano MG, Pugliese M, Gargantini E, International Journal of Cancer =: Journal International du Cancer . 2012,第3期

机译：组蛋白脱乙酰基酶抑制剂panobinostat（LBH589）在间变性甲状腺癌体内外的细胞毒活性。
4. Antitumor Activity of Escin in Mice Cervical Carcinoma U_(14) in vivo and Human Cervical Carcinoma Hela Cell Line in vitro [C] . Xueying Zhou, Changhai Wang, Fenghua Fu The 3rd International Conference on Bioinformatics and Biomedical Engineering(iCBBE 2009)(第三届生物信息与生物医学工程国际会议）论文集 . 2009

机译：Escin在小鼠宫颈癌U_（14）和人宫颈癌Hela细胞系中的抗肿瘤活性
5. The Role of Online Support for Anaplastic Thyroid Cancer Patients and Survivors [D] . Nixon, Bevin J. 2019

机译：在线支持对共产性甲状腺癌患者和幸存者的作用
6. PARP inhibitor olaparib increases the oncolytic activity of dl922‐947 in in vitro and in vivo model of anaplastic thyroid carcinoma [O] . Carmela Passaro, Massimiliano Volpe, Ginevra Botta, 2015

机译：PARP抑制剂olaparib在间变性甲状腺癌的体外和体内模型中增加dl922-947的溶瘤活性
7. PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma [O] . Passaro, Carmela, Volpe, Massimiliano, Botta, Ginevra, 2015

机译：paRp抑制剂奥拉帕尼增加dl922-947在甲状腺未分化癌体外和体内模型中的溶瘤活性

PARP inhibitor AZD2281 increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅